Edition:
India

Suven Life Sciences Ltd (SUVP.NS)

SUVP.NS on National Stock Exchange of India

260.05INR
16 Oct 2019
Change (% chg)

Rs-5.65 (-2.13%)
Prev Close
Rs265.70
Open
Rs267.70
Day's High
Rs267.75
Day's Low
Rs258.80
Volume
196,924
Avg. Vol
168,633
52-wk High
Rs304.40
52-wk Low
Rs182.70

Latest Key Developments (Source: Significant Developments)

Suven Life Sciences Secures Product Patents In Israel,Japan, New Zealand & Sri Lanka
Wednesday, 3 Apr 2019 

April 3 (Reuters) - Suven Life Sciences Ltd ::SECURES PRODUCT PATENTS IN ISRAEL, JAPAN, NEW ZEALAND AND SRI LANKA.PATENTS FOR CHEMICAL ENTITIES FOR TREATMENT OF DISORDERS OF NEURODEGENERATIVE DISEASES.  Full Article

Suven Life Sciences Gets Product Patents In Eurasia, Europe, South Korea And Sri Lanka
Friday, 29 Mar 2019 

March 29 (Reuters) - Suven Life Sciences Ltd ::SAYS SUVEN LIFE SCIENCES SECURES PRODUCT PATENTS IN EURASIA, EUROPE, SOUTH KOREA AND SRI LANKA.SUVEN LIFE SCIENCES - PATENTS CORRESPONDING TO NEW CHEMICAL ENTITIES FOR TREATMENT OF DISORDERS RELATED TO NEURODEGENERATIVE DISEASES.SUVEN LIFE SCIENCES - PATENTS ARE VALID THROUGH 2034.  Full Article

Suven Life Sciences Buys Shares Of Suven Pharmaceuticals From Its Existing Shareholders
Tuesday, 5 Feb 2019 

Feb 5 (Reuters) - Suven Life Sciences Ltd ::ACQUIRED ALL SHARES OF SUVEN PHARMACEUTICALS FROM ITS EXISTING SHAREHOLDERS.  Full Article

Suven Life Sciences Gets Product Patents In New Zealand And Sri Lanka
Friday, 14 Sep 2018 

Sept 14 (Reuters) - Suven Life Sciences Ltd ::SAYS GETS PRODUCT PATENTS IN NEW ZEALAND AND SRI LANKA.SUVEN LIFE SCIENCES -PATENTS FOR CHEMICAL ENTITY FOR TREATMENT OF DISORDERS FOR NEURODEGENERATIVE DISEASES; VALID THROUGH 2034 AND 2031 RESPECTIVELY.  Full Article

Suven Life Sciences Gets Product Patents In India, Singapore,South Korea And Israel
Wednesday, 4 Jul 2018 

July 4 (Reuters) - Suven Life Sciences Ltd ::SECURES PRODUCT PATENTS IN INDIA, SINGAPORE,SOUTH KOREA AND ISRAEL.SAYS PATENTS ARE VALID THROUGH 2031, 2034, 2034 AND 2036.SUVEN LIFE SCIENCES - GRANT OF PATENTS CORRESPONDING TO NEW CHEMICAL ENTITIES FOR TREATMENT OF DISORDERS ASSOCIATED WITH NEURODEGENERATIVE DISEASES.  Full Article

Suven Life Sciences Secures Product Patents In New Zealand And USA
Tuesday, 29 May 2018 

May 29 (Reuters) - Suven Life Sciences Ltd ::SAYS CO SECURES PRODUCT PATENTS IN NEW ZEALAND AND USA.PATENTS ARE VALID THROUGH 2034.SAYS PATENTS CORRESPONDING TO NEW CHEMICAL ENTITIES FOR TREATMENT OF DISORDERS ASSOCIATED WITH NEURODEGENERATIVE DISEASES.  Full Article

India's Suven Life Sciences March Qtr Profit Rises
Tuesday, 15 May 2018 

May 15 (Reuters) - Suven Life Sciences Ltd ::MARCH QUARTER NET PROFIT 625.1 MILLION RUPEES VERSUS PROFIT 400.7 MILLION RUPEES YEAR AGO.MARCH QUARTER TOTAL REVENUE FROM OPERATIONS 2.14 BILLION RUPEES VERSUS 1.80 BILLION RUPEES YEAR AGO.  Full Article

Suven Life Sciences Says FDA Observed Some Procedures Are Deficient During Medak Unit Inspection
Tuesday, 24 Apr 2018 

April 24 (Reuters) - Suven Life Sciences Ltd ::SUVEN LIFE SCIENCES - FDA DURING INSPECTION OF PASHAMYLARAM, MEDAK UNIT OBSERVED THERE ARE PROCEDURES FOLLOWED ON CERTAIN ASPECTS WHICH ARE DEFICIENT.SAYS CO REVISED STANDARD OPERATING PROCEDURES AS CORRECTIVE ACTION.  Full Article

Suven Life Sciences Secures Product Patents In Canada, India
Thursday, 21 Dec 2017 

Dec 21 (Reuters) - Suven Life Sciences Ltd ::‍SAYS SECURES PRODUCT PATENTS IN CANADA AND INDIA.SAYS PATENT CORRESPONDING TO NEW CHEMICAL ENTITIES (NCES) FOR TREATMENT OF DISORDERS ASSOCIATED WITH NEURODEGENERATIVE DISEASES.SAYS CANADA AND INDIA PATENTS ARE VALID THROUGH 2034 AND 2028 ‍​RESPECTIVELY.  Full Article

  • Previous
  • Next

Suven Life Sciences Ltd News

» More SUVP.NS News

Earnings vs. Estimates

» More Financials